The pharmaceutical and nutraceutical industries have traditionally relied on Hydroxypropyl Methylcellulose (HPMC) and Polyvinyl Alcohol (PVA) as the standard polymers for immediate release coatings for solid oral dosage forms. These polymers are commonplace due to their robustness and well understood film-forming properties. However, the increasing global emphasis on sustainability, efficiency, and consumer-friendly solutions necessitates the exploration of innovative alternatives.
This webinar will describe a film-coating solution which originates from pea-starch
and provides formulators with a solution which allows
more sustainability, process efficiency, patient adherence and
consumer experience for their pharmaceutical and nutraceutical formulations.
What can you learn in this webinar?
✅Key factors in selecting the right film coating technology
- Purpose of coatings.
- Types of coatings for immediate release in the market and the relative advantages/applications of each.
- Coating process steps.
- Considerations when choosing a coating.
✅How starch-based coatings compare to HPMC and PVA
- Suspension preparation
- Coating parameters – highlighting low temp starch coating
- Film properties – tensile strength, elasticity, adhesion
- Coating gloss, color, rugosity
- Ease of equipment cleaning for starch-based vs HPMC
✅Ways to save time, energy, and costs in your coating process
- Efficiency gains – in process time and cleaning
- Power consumption comparison – savings due to lower process temperature and shorter processing time
- Benefits of processing at low temperature
- Alternative to organic solvent-based coatings using either HPMC or PVA
- Less risk of degradation or oxidation
Date & Time & Timezone: Thursday, Mar 27, 2025 03:00 PM CET, 9:00 AM EST
Speaker:
Peter Freed
Head of Global Pharma Customer Technical Support, Roquette
Peter Freed is Head of Global Pharma Customer Technical Support at Roquette, overseeing pharmaceutical services worldwide.
Previously, he served as Director of Formulation Development at Pace® Life Sciences and Emerson Resources, leading teams in drug product development, cGMP manufacturing, and scientific research.
With a Ph.D. in Pharmaceutical Sciences from Temple University, Peter specializes in amorphous spray-dried dispersions and solubility enhancement. His extensive experience spans across multiple pharmaceutical disciplines, making him a recognized expert in formulation development and manufacturing processes.
Arnaud Verhaeghe
Global Head of Marketing for the Oral Dosage Market, Roquette
Arnaud Verhaeghe is a bilingual global business executive with over 25 years of experience in life sciences, oil and energy, electronics, and chemicals.
He is currently the Global Head of Marketing for the Oral Dosage Market at Roquette Pharma Global Business Unit.
Previously, he led the Omnichannel Group Program at Roquette and managed the Research Chemicals division at Honeywell.
At Sigma-Aldrich, he served as VP of Research Chemicals and EMEA Sales Director. His early career at Air Liquide involved roles such as Financial of Air Liquide Welding Controller and Branch Manager of the South Korea Branch. Arnaud holds an Executive MBA from EM Lyon, executive education from Northwestern Kellogg and INSEAD, and an engineering degree from ICAM.
For more information & registration click here:
